Songkla University unveils CAR-T therapy with 90% cancer treatment success rate
SONGKHLA — The Faculty of Medicine at Prince of Songkla University (PSU) has unveiled progress in using locally developed CAR-T Cell therapy to treat blood cancers and autoimmune diseases, reporting that nearly 90% of patients have achieved complete remission. Asst. Prof. Dr. Nalinee Kowitwanawong, deputy dean for administration at the Faculty of Medicine, said on […] The post Songkla University…
Prince of Songkla University (PSU) has made significant strides in the field of CAR-T Cell therapy, a treatment that has demonstrated near 90% success in eradicating blood cancers and autoimmune diseases. Assistant Professor Dr. Nalinee Kowitwanawong announced on August 4, 2026, that the Faculty of Medicine at PSU has implemented this therapy for patients suffering from lymphoma, leukemia, and systemic lupus erythematosus (SLE).
This therapy involves genetically modifying a patient's own immune cells to identify and combat specific cells. The university's director of the Centre of Excellence for Stem Cell Transplantation and Cell Therapy, Assoc. Prof. Dr. Chakkarawadee Chulamanee, revealed that the locally developed treatment offers substantial cost savings compared to imported options, which can exceed 20 million baht, now reduced to approximately 2 million baht.
To boost production, PSU's Faculty of Medicine is constructing a facility to manufacture CD19 CAR-T Cells, aiming to increase annual patient capacity from 30 to over 100. The university is also seeking collaborations with private entities and international networks to enhance accessibility and further refine the technology for global application.
A notable partnership with Bangkok Hospital Phuket has been established, merging PSU's academic prowess with Bangkok Hospital Phuket's medical resources to create a robust framework for precision medicine and advanced therapy medicinal products, alongside comprehensive patient care. This initiative aims to bring advanced medical treatments to the Andaman coastal region, the southern part of Thailand, and international patients, positioning the area as a global leader in advanced medicine.
Dr. Chakkarawadee emphasized that the project aligns with broader goals of elevating regional medical standards, ensuring patient safety, and achieving positive outcomes for patients.
Written by urgent.news from Khaosod English's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
